Cancer Research

Revolutionary Laser Technique Enhances Noninvasive Metabolic Imaging
Research & Development Revolutionary Laser Technique Enhances Noninvasive Metabolic Imaging

In a groundbreaking advancement, MIT researchers have developed a revolutionary technique in the realm of metabolic imaging. This noninvasive method utilizes laser light to study living cells, providing valuable insights into disease progression and treatment responses. Traditional metabolic

High-Dose Chemotherapy and ASCT No Extra Benefit in MCL Remission
Research & Development High-Dose Chemotherapy and ASCT No Extra Benefit in MCL Remission

The findings from the late-breaking research presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition have brought new insights into the treatment of mantle cell lymphoma (MCL). The phase 3 study EA4151, conducted by the ECOG-ACRIN Cancer Research Group, investigated

Accelerated Aging Increases Risk for Early-Onset Colorectal Cancer
Research & Development Accelerated Aging Increases Risk for Early-Onset Colorectal Cancer

New research conducted by the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has revealed a significant connection between accelerated aging and an increased risk of early-onset colorectal cancer. This groundbreaking study sheds light on the importance of

Can High-Fructose Corn Syrup Fuel Cancer Growth and Spread?
Research & Development Can High-Fructose Corn Syrup Fuel Cancer Growth and Spread?

The relationship between dietary fructose, particularly from high-fructose corn syrup, and cancer growth is a topic of growing concern. Over the past few decades, the consumption of high-fructose corn syrup has skyrocketed. While naturally occurring fructose in fruits, vegetables, and honey is

Patient-Derived Glioblastoma Organoids Advance Personalized CAR-T Therapy
Tech & Innovation Patient-Derived Glioblastoma Organoids Advance Personalized CAR-T Therapy

Researchers at the Perelman School of Medicine at the University of Pennsylvania have made a significant breakthrough in personalized medicine and cancer treatment. By using patient-derived glioblastoma (GBM) organoids, they have developed a method to model patient responses to CAR-T cell therapy

Certis Oncology Launches AI Chatbot to Boost Cancer Research Efficiency
Research & Development Certis Oncology Launches AI Chatbot to Boost Cancer Research Efficiency

Certis Oncology Solutions has introduced a groundbreaking innovation: the CertisOI Assistant™, an AI-powered chatbot aimed at significantly enhancing the efficiency of preclinical oncology research. Leveraging the capabilities of artificial intelligence, machine learning (AI/ML), and OpenAI’s

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later